Demant A/S (OTCMKTS:WILYY - Get Free Report) was upgraded by analysts at The Goldman Sachs Group to a "strong-buy" rating in a report issued on Monday, Zacks.com reports.
A number of other equities analysts have also recently issued reports on the company. Hsbc Global Res upgraded Demant A/S to a "hold" rating in a report on Friday, September 13th. UBS Group raised Demant A/S to a "strong-buy" rating in a research note on Wednesday, August 28th.
View Our Latest Stock Analysis on Demant A/S
Demant A/S Stock Performance
WILYY remained flat at $19.26 on Monday. 11 shares of the company traded hands, compared to its average volume of 1,481. The stock's 50 day simple moving average is $20.08 and its 200 day simple moving average is $21.40. Demant A/S has a 52 week low of $17.60 and a 52 week high of $27.06.
Demant A/S Company Profile
(
Get Free Report)
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services.
Featured Stories
Before you consider Demant A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Demant A/S wasn't on the list.
While Demant A/S currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
